ANTICORPS ANTI-CD20 OU FRAGMENTS CORRESPONDANTS POUR LE TRAITEMENT DE SYNDROME DE FATIGUE CHRONIQUE

• 收藏
• 分享

专利权人:

Bergen Teknologioverføring AS

发明人:

申请号：

EP09700128.3

公开号：

EP2235060B1

申请日:

2009.01.02

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to an anti-CD20 antibody or a CD20-binding antibody fragment thereof for the treatment of chronic fatigue syndrome and myalgic encephalomyelitis. In particular, the present invention relates to the use of anti-CD20 monoclonal antibodies or fragments thereof which are preferably humanized for the treatment of the chronic fatigue syndrome/myalgic encephalomyelitis in a subject afflicted with said disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/